Bayer shares gave up gains from a rally triggered by its plan to settle legal battles over Roundup weedkiller, which prompted the company to increase litigation provisions and forecast it would burn ...

Bayer reached a preliminary deal to settle litigation on the Roundup weedkiller. Bayer stock slumped on Wednesday as the German giant set a preliminary accord to cap litigation over its weedkiller ...

Bayer's shares slumped as much as 9.2% on Wednesday, wiping out the previous day's gains, as investors questioned whether a ...

Bayer's agrochemicals unit Monsanto has filed lawsuits in the US against the manufacturers of mRNA-based COVID-19 vaccines, claiming that they used its patent-protected technology in their products.

CALGARY, Alberta--(BUSINESS WIRE)--Bayer Crop Science today announced an unprecedented $45+ million CAD investment to strengthen Canada’s leadership in canola innovation by establishing a cutting-edge ...

Investing.com -- Bayer AG shares jumped more than 7% on Monday after the U.S. Supreme Court agreed to hear the German company’s appeal in a key Roundup weedkiller lawsuit, raising hopes of a favorable ...

The US Supreme Court agreed on Friday to hear Bayer’s bid to sharply limit lawsuits claiming that the company’s Roundup weedkiller causes cancer and potentially avert billions of dollars in damages.

Investing.com -- Bayer AG (OTC:BAYRY) stock surged 5% on Friday after the U.S. Supreme Court agreed to hear the company’s appeal challenging a $1.25 million Missouri jury verdict related to its ...

Shares in Bayer jumped 6% after Finnish pharmaceutical company Orion predicted strong growth for darolutamide, a prescription prostate-cancer medication on which the two companies partner. Bayer stock ...

Bayer is re-entering key assets in the US market under new indications to reclaim lost profits from patent expirations for its flagship therapies, a move it notes cannot be relied upon to face future ...

Bayer's transformation focuses on a revitalized portfolio, strong pipeline, and strategic operational changes for sustained growth. New product launches generated $1.7 billion in revenue, highlighting ...

German life sciences giant Bayer believes a change to European Union policy on gene-edited crops has the potential to reshape Europe’s €6 billion seed market and vindicate its troubled acquisition of ...